Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (CASE: RMDA)
Health Care · Pharmaceuticals · EG
EGP5.45
-5.55% today · +68.5% 1Y
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (CASE: RMDA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $211.63M.
Over the last twelve months the share price has gained 68.5%, trading between 3.06 and 7.39.
Tweenvest scores Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) across four factors: quality 59/100, value 20/100, growth 79/100, dividend 29/100. Its strongest factor is growth.
RMDA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $211.63M
- Revenue (TTM)
- $89.31M
- P/E
- 36.58
- EPS
- 0.15
- Dividend yield
- 0.74%
- Beta (5Y)
- 0.44
- 52-week high
- EGP7.39
- 52-week low
- EGP3.06
- Avg volume (3M)
- —
- Shares outstanding
- 2.03B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fredun Pharmaceuticals LimitedBSE: 539730 | $232.40M | Rs1,353.00 | -0.58% |
| JW Holdings CorporationKOSE: A096760 | $220.15M | ₩4,285.00 | -0.92% |
| Beta Drugs LimitedNSEI: BETA | $218.29M | Rs2,073.30 | -1.21% |
| Imexpharm CorporationHOSE: IMP | $216.92M | ₫36,600.00 | -0.81% |
| SCI Pharmtech, Inc.TWSE: 4119 | $208.59M | NT$55.60 | -1.94% |
| Newron Pharmaceuticals S.p.A.SWX: NWRN | $207.97M | CHF8.12 | -22.37% |
| Huons Global Co., Ltd.KOSDAQ: A084110 | $204.40M | ₩22,550.00 | +5.87% |
| Savior Lifetec CorporationTPEX: 4167 | $203.48M | NT$19.55 | +0.77% |
Figures last refreshed Oct 4, 2026.